U E Kongsgaard1, M Y Wang, G Kvalheim. 1. Department of Anaesthesiology and Oncology, The Norwegian Radium Hospital, Oslo, Norway.
Abstract
BACKGROUND: Autologous blood transfusion has been avoided in cancer surgery because of the metastatic potential of reinfused tumour cells. METHODS: This study evaluated the efficacy of a blood transfusion filter in removing tumour cells from blood. Whole human blood was admixed with two different malignant cell lines (breast cancer PM1 and MCF7). The blood was filtered through a RC400TE leucocyte depletion filter. Unfiltered blood was used as a control. Detection of malignant cells was performed with immunomagnetic beads and clonogenic assays. RESULTS: No viable tumour cells were found after filtration with the leucocyte depletion filter. CONCLUSION: These findings suggest that the use of a leucocyte filter after intra-operative blood salvage may make autotransfusion safe even in tumour surgery.
BACKGROUND: Autologous blood transfusion has been avoided in cancer surgery because of the metastatic potential of reinfused tumour cells. METHODS: This study evaluated the efficacy of a blood transfusion filter in removing tumour cells from blood. Whole human blood was admixed with two different malignant cell lines (breast cancerPM1 and MCF7). The blood was filtered through a RC400TE leucocyte depletion filter. Unfiltered blood was used as a control. Detection of malignant cells was performed with immunomagnetic beads and clonogenic assays. RESULTS: No viable tumour cells were found after filtration with the leucocyte depletion filter. CONCLUSION: These findings suggest that the use of a leucocyte filter after intra-operative blood salvage may make autotransfusion safe even in tumour surgery.
Authors: Paolo Feltracco; Marialuisa Brezzi; Stefania Barbieri; Helmut Galligioni; Moira Milevoj; Cristiana Carollo; Carlo Ori Journal: World J Hepatol Date: 2013-01-27
Authors: Thomas Frietsch; Andrea U Steinbicker; Audrey Horn; Matthes Metz; Gerald Dietrich; Markus A Weigand; Jonathan H Waters; Dania Fischer Journal: Transfus Med Hemother Date: 2022-05-11 Impact factor: 4.040